High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

Breast Cancer Research and Treatment

Volumn 129, Issue 1, 2011, Pages 1-9

  Martins, Ana Teresa ^a   Monteiro, Paula ^a   Ramalho Carvalho, João ^a   Costa, Vera L ^a   Dinis Ribeiro, Mário ^a,b   Leal, Conceição ^a   Henrique, Rui ^a,c   Jerónimo, Carmen ^a,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Breast cancer; Epigenetic profile; Fine needle aspirates; Prognosis; Quantitative DNA methylation

Indexed keywords

ADENOMATOUS POLYPOSIS COLI GENE; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYCLIN D2 GENE; CYTOPATHOLOGY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DNA METHYLATION; FEMALE; GENE; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1 GENE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; DNA METHYLATION; EPIGENOMICS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 79960847694     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1160-0     Document Type: Article

References (26)

1. J Ferlay DM Parkin E Steliarova-Foucher 2010 Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 765 781 20116997 10.1016/j.ejca.2009.12.014 1:STN:280:DC%2BC3c7js1CktA%3D%3D
2. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 4 225 249 19474385 10.3322/caac.20006
3. C Jeronimo I Costa MC Martins P Monteiro S Lisboa C Palmeira, et al. 2003 Detection of gene promoter hypermethylation in fine needle washings from breast lesions Clin Cancer Res 9 9 3413 3417 12960130 1:CAS:528:DC%2BD3sXotFCktr8%3D (Pubitemid 37082737)
4. CF Nemec J Listinsky A Rim 2007 How should we screen for breast cancer? Mammography, ultrasonography, MRI Clevel Clin J Med 74 12 897 904 10.3949/ccjm.74.12.897
5. J Hamill ID Campbell F Mayall AS Bartlett A Darlington 2002 Improved breast cytology results with near patient FNA diagnosis Acta Cytol 46 1 19 24 11845809 10.1159/000326710 (Pubitemid 34111419)
6. M Esteller 2008 Epigenetics in cancer N Engl J Med 358 11 1148 1159 18337604 10.1056/NEJMra072067 1:CAS:528:DC%2BD1cXjt1ahs7Y%3D (Pubitemid 351398489)
7. M Esteller 2007 Cancer epigenomics: DNA methylomes and histone-modification maps Nat Rev Genet 8 4 286 298 17339880 10.1038/nrg2005 1:CAS:528:DC%2BD2sXivVGktbk%3D (Pubitemid 46439286)
8. RA Hinshelwood SJ Clark 2008 Breast cancer epigenetics: normal human mammary epithelial cells as a model system J Mol Med 86 12 1315 1328 18716754 10.1007/s00109-008-0386-3
9. JW Liu JK Nagpal C Jeronimo JE Lee R Henrique MS Kim, et al. 2008 Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer Prostate 68 4 418 426 18196513 10.1002/pros.20709 1:CAS:528:DC%2BD1cXkt1ygu7s%3D (Pubitemid 351342647)
10. PK Lo S Sukumar 2008 Epigenomics and breast cancer Pharmacogenomics 9 12 1879 1902 19072646 10.2217/14622416.9.12.1879 1:CAS:528:DC%2BD1cXhsFWjtbrE
11. Page DL, Sakamoto G (1987) Infiltrating carcinoma: major histological types. Churchill-Livingstone, Edinburgh
12. Elston CW, Ellis IO (1998) Assessment of histological grade. Churchill Livingstone, Edinburgh
13. Greene FLPD, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
14. SJ Clark J Harrison CL Paul M Frommer 1994 High sensitivity mapping of methylated cytosines Nucleic Acids Res 22 15 2990 2997 8065911 10.1093/nar/22.15.2990 1:CAS:528:DyaK2cXlvFOjsL4%3D (Pubitemid 24260626)
15. CA Eads KD Danenberg K Kawakami LB Saltz C Blake D Shibata, et al. 2000 MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Res 28 8 E32 10734209 10.1093/nar/28.8.e32 1:CAS:528:DC%2BD3cXmtlGgsLk%3D
16. U Lehmann F Langer H Feist S Glockner B Hasemeier H Kreipe 2002 Quantitative assessment of promoter hypermethylation during breast cancer development Am J Pathol 160 2 605 612 11839581 10.1016/S0002-9440(10)64880-8 1:CAS:528:DC%2BD38XitVCkt7w%3D (Pubitemid 34160338)
17. C Jeronimo R Henrique MO Hoque FR Ribeiro J Oliveira D Fonseca, et al. 2004 Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker Clin Cancer Res 10 12 Pt 1 4010 4014 15217932 10.1158/1078-0432.CCR-03-0643 1:CAS:528:DC%2BD2cXltFWmtbo%3D (Pubitemid 38812475)
18. R Henrique FR Ribeiro D Fonseca MO Hoque AL Carvalho VL Costa, et al. 2007 High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients Clin Cancer Res 13 20 6122 6129 17947477 10.1158/1078-0432.CCR-07-1042 1:CAS:528:DC%2BD2sXhtFygs7fL (Pubitemid 350075071)
19. RT Pu LE Laitala PM Alli MJ Fackler S Sukumar DP Clark 2003 Methylation profiling of benign and malignant breast lesions and its application to cytopathology Mod Pathol 16 11 1095 1101 14614048 10.1097/01.MP.0000095782. 79895.E2 (Pubitemid 37414203)
20. E Dulaimi J Hillinck I Ibanez de Caceres T Al-Saleem P Cairns 2004 Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients Clin Cancer Res 10 18 Pt 1 6189 6193 15448006 10.1158/1078-0432.CCR-04-0597 1:CAS:528:DC%2BD2cXnvVOjs7Y%3D (Pubitemid 39287525)
21. VJ Bardou G Arpino RM Elledge CK Osborne GM Clark 2003 Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases J Clin Oncol 21 10 1973 1979 12743151 10.1200/JCO.2003.09.099 1:CAS:528:DC%2BD2cXptlCksbg%3D (Pubitemid 46606386)
22. DM Euhus D Bu S Milchgrub XJ Xie A Bian AM Leitch, et al. 2008 DNA methylation in benign breast epithelium in relation to age and breast cancer risk Cancer Epidemiol Biomarkers Prev 17 5 1051 1059 18483325 10.1158/1055-9965.EPI-07-2582 1:CAS:528:DC%2BD1cXmtVClsLw%3D
23. I Van Der Auwera C Bovie C Svensson XB Trinh R Limame P van Dam, et al. 2010 Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients BMC Cancer 10 97 20226036 10.1186/1471-2407-10-97
24. Z Jin G Tamura T Tsuchiya K Sakata M Kashiwaba M Osakabe, et al. 2001 Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers Br J Cancer 85 1 69 73 11437404 10.1054/bjoc.2001.1853 1:CAS:528:DC%2BD3MXlvVKhtbg%3D (Pubitemid 32695718)
25. HM Muller A Widschwendter H Fiegl L Ivarsson G Goebel E Perkmann, et al. 2003 DNA methylation in serum of breast cancer patients: an independent prognostic marker Cancer Res 63 22 7641 7645 14633683 (Pubitemid 37466689)
26. MO Hoque Q Feng P Toure A Dem CW Critchlow SE Hawes, et al. 2006 Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer J Clin Oncol 24 26 4262 4269 16908936 10.1200/JCO.2005.01.3516 1:CAS:528:DC%2BD28XhtVGju7jN (Pubitemid 46630783)